No-moat Clinuvel CUV is suspending early-stage clinical trials evaluating afamelanotide, a synthetic drug already used in its ...

Today I’m going to think a bit about step four and beyond: how an investor might find potential investments that are aligned ...

With the cost of education increasing and federal re-election campaigns fired up, find out what new changes to HECS may mean ...

Munger wanted to make a point about what it takes to be successful at investing or anything else in life. He said, “the first ...

Signs of improvement in continued improvement in core business.

In the pursuit of continued earnings growth, Aristocrat is at risk of overpaying for acquisitions in its competitively more ...

Recent election results have sent US markets into a record-high rally however implications remain mixed for the Australian ...

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, ...

New research reveals undiagnosed cognitive decline can cost retirees tens of thousands of dollars through bad investments or ...

Tesla shares rose roughly 28% this past week on news that Donald Trump was elected to become the next US president. The ...

This week's chart of the week looks at the correlation of stock and bond markets since 2022, and whether this nullifies the ...

We re-confirm our Gold Medalist rating on the low-cost ETF.